Sabinsa Corporation (East Windsor, NJ) has received a Foreign Site Registration Number for its Payson, UT finished product-manufacturing facility from Health Canada’s Natural and Non Prescription Health Product Directorate (NNHPD). This Sabinsa manufacturing plant was recently assessed by NHPD for Natural Health Product’s GMP (good manufacturing practice) standards and quality system and was deemed as compliant for manufacturing health products. Foreign Sire Reference Number 5000311 allows Sabinsa to manufacture Natural Health Products for the Canadian market in the Utah facility. The Utah facility is also NSF certified.
Sabinsa Corporation already had multiple Masterfiles and Natural Product Numbers (NPN) approved for use in Canada, which allows several of its extracts in the form of finished products in the Canadian market. LactoSpore, BioPerine, Curcumin C3 Complex, Curcumin C3 Reduct and ForsLean, among Sabinsa’s proprietary products, are available for Letter of Access requests. The most recent NPN obtained by Sabinsa is for their room temperature stable probiotic, LactoSpore MTCC 5856.
“Availability of the NPNs with Sabinsa’s original, science-backed ingredients and the Foreign Site license for our Utah facility will greatly benefit our customers by considerably reducing the time required for product launches in the Canadian market,” said Shaheen Majeed, marketing director, Sabinsa Corp. “As a global company, working with regulatory agencies in an array of countries has become customary for us, but it is always rewarding to achieve another milestone like this one.”
For more information, call (732) 777-1111 or visit www.sabinsa.com.